149 related articles for article (PubMed ID: 8105944)
1. Successful use of zero calcium dialysate to treat hypercalcemia in a postsurgical peritoneal dialysis patient.
Mars RL
Adv Perit Dial; 1993; 9():284-7. PubMed ID: 8105944
[TBL] [Abstract][Full Text] [Related]
2. Low calcium (2.5 mEq/l) and high calcium (3.5 mEq/l) dialysate in peritoneal dialysis patients.
Wadhwa NK; Howell N; Suh H; Cabralda T
Adv Perit Dial; 1992; 8():385-8. PubMed ID: 1361829
[TBL] [Abstract][Full Text] [Related]
3. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
[TBL] [Abstract][Full Text] [Related]
4. Calcium mass transfer in peritoneal dialysis patients using 2.5 mEq/l calcium dialysate.
Piraino B; Bernardini J; Holley J; Johnston JR; Perlmutter JA; Martis L
Clin Nephrol; 1992 Jan; 37(1):48-51. PubMed ID: 1541065
[TBL] [Abstract][Full Text] [Related]
5. Dialysate calcium profiling during hemodialysis: use and clinical implications.
Kyriazis J; Glotsos J; Bilirakis L; Smirnioudis N; Tripolitou M; Georgiakodis F; Grimani I
Kidney Int; 2002 Jan; 61(1):276-87. PubMed ID: 11786110
[TBL] [Abstract][Full Text] [Related]
6. Review of dialysate calcium concentration in hemodialysis.
Toussaint N; Cooney P; Kerr PG
Hemodial Int; 2006 Oct; 10(4):326-37. PubMed ID: 17014507
[TBL] [Abstract][Full Text] [Related]
7. Hypercalcemia in patients treated with CAPD.
Orłowska-Kowalik G; Ksiazek A
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):479-84. PubMed ID: 16146134
[TBL] [Abstract][Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
9. [Optimum calcium concentration in the dialysate].
Nakazawa R
Clin Calcium; 2004 Sep; 14(9):84-7. PubMed ID: 15577117
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
[TBL] [Abstract][Full Text] [Related]
11. The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder.
Cheng IK; Lu HB; Chan CY; Cheng SW; Robinson JD; Tam SC; Lo WK; Cheung WC
Clin Nephrol; 1993 Aug; 40(2):100-5. PubMed ID: 8222365
[TBL] [Abstract][Full Text] [Related]
12. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis.
Toussaint ND; Polkinghorne KR; Kerr PG; Somerville CA; Agar JW
Hemodial Int; 2007 Apr; 11(2):217-24. PubMed ID: 17403174
[TBL] [Abstract][Full Text] [Related]
13. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
[TBL] [Abstract][Full Text] [Related]
14. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration.
Al-Hejaili F; Kortas C; Leitch R; Heidenheim AP; Clement L; Nesrallah G; Lindsay RM
J Am Soc Nephrol; 2003 Sep; 14(9):2322-8. PubMed ID: 12937309
[TBL] [Abstract][Full Text] [Related]
15. Calcium exposure and removal in chronic hemodialysis patients.
Sigrist M; McIntyre CW
J Ren Nutr; 2006 Jan; 16(1):41-6. PubMed ID: 16414440
[TBL] [Abstract][Full Text] [Related]
16. Dialysate calcium individualisation: a pending issue.
Maduell F; Rodríguez N; Arias-Guillén M; Jiménez S; Alemany B; Durán C; Fontseré N; Vera M; Carrera M; Arcal C; Pérez N; Cases A; Campistol JM
Nefrologia; 2012; 32(5):579-86. PubMed ID: 23013943
[TBL] [Abstract][Full Text] [Related]
17. Marked improvement in bone metabolism parameters after increasing the dialysate calcium concentration from 2.5 to 3 mEq/L in nonhypercalcemic hemodialysis patients.
Molina Vila P; Sánchez Pérez P; Garrigós Almerich E; Peris Domingo A
Hemodial Int; 2008 Jan; 12(1):73-9. PubMed ID: 18271845
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects on PTH and mineral metabolism of 1.25 versus 1.75 mmol/L dialysate calcium in peritoneal dialysis patients: a meta-analysis.
Jin L; Zhou J; Shao F; Yang F
BMC Nephrol; 2019 Jun; 20(1):213. PubMed ID: 31185931
[TBL] [Abstract][Full Text] [Related]
19. An analysis of the effectiveness and benefits of peritoneal dialysis and haemodialysis using Nigerian made PD fluids.
Arogundade FA; Ishola DA; Sanusi AA; Akinsola A
Afr J Med Med Sci; 2005 Sep; 34(3):227-33. PubMed ID: 16749353
[TBL] [Abstract][Full Text] [Related]
20. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
